Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Cutter

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Veterinary Pathology|July 4, 2007
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaS P Fosmire, R Thomas, C M Jubala, et al.
Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2009
Proof of concept studies for tissue-protective agents in multiple sclerosisL R Mehta, S R Schwid, D L Arnold, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Veterinary Pathology|July 4, 2007
Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphomaS P Fosmire, R Thomas, C M Jubala, et al.
Neurology|November 26, 2003
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional CompositeL J Balcer, M L Baier, J A Cohen, et al.
Neurology|March 26, 2008
Ethics of placebo-controlled clinical trials in multiple sclerosis: a reassessmentC H Polman, S C Reingold, F Barkhof, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 25, 2009
Proof of concept studies for tissue-protective agents in multiple sclerosisL R Mehta, S R Schwid, D L Arnold, et al.
Pageof 13